Moderna SHORT; Silver BUY
SHORT MODERNA…Being very negative on the stock market (short NASDAQ futures as we write), I have been looking to get back into shorting specific stocks and am now short @ $186 per share MODERNA (symbol MRNA)…Moderna is the smallest of the three covid vaccine producers. The stock has been under pressure due in part to a report last month that the Moderna vaccine when compared to 800 pound gorilla Pfizer…” is up to four times more likely to cause inflammation of the heart muscle, a very rare side effect, than its rival vaccine from Pfizer-BioNTech, according to a Danish study published in the British Medical Journal.”
I believe that another reason MRNA may go much lower is growth in sales and earnings in 2022 after the boom in 2021 is problematic. Also in general stocks priced at more than 2 times book, I stay away from. Moderna even after its recent drop is selling at over 7 times book.
Finally Moderna is vulnerable because of the publicity from interviews before the MASSIVE Joe Rogan Experience audience by two very eminent and credible medical experts- Dr Robert Malone and Dr Peter McCullough- who both express major concerns about the safety and efficacy of the Covid vaccines in general.
Robert Malone https://rumble.com/vrrdsc-dr.-robert-malone-explains-how-dire-the-situation-is-in-the-usa-full-interv.html
Peter McCullough https://rumble.com/vqx8ma-dr-peter-mccullough-with-joe-rogan-the-joe-rogan-experience-1747.html
BUY SILVER…I have added to my long position in silver futures because for the first time silver can move higher from currently depressed levels even when interest rates are moving up as well. The US government has for several years used higher interest rates as a rationale to drive down the price of gold and silver in the futures markets. But in today’s trading both interest rate futures (T-Bond as well as Eurodollar) AND silver futures showed strong up moves. Therefore I bought more silver futures @ 23.50 per ounce.
Big Bob Primarily Betting on Higher Interest Rates- but a little diversification doesn’t hurt